WealthShield Partners’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-128
Closed -$4.77K 574
2025
Q3
$4.77K Hold
128
﹤0.01% 526
2025
Q2
$4.15K Hold
128
﹤0.01% 518
2025
Q1
$3.44K Buy
+128
New +$3.75K ﹤0.01% 508
2021
Q3
Sell
-1,069
Closed -$50K 404
2021
Q2
$50K Sell
1,069
-659
-38% -$29.8K 0.01% 473
2021
Q1
$76K Buy
+1,728
New +$78.4K 0.01% 384

Other funds holding FFTY

WealthShield Partners's FFTY Position: Q4 2025 in Review

WealthShield Partners sold out of CapForce IBD 50 ETF (FFTY) in Q4 2025, closing a stake of 128 shares — an estimated $4.77K sold.

WealthShield Partners first reported a position in FFTY in Q1 2021 and held it in 5 quarters. The position peaked at $76K in Q1 2021. 41 funds tracked by Wall St. Rank hold FFTY as of Q4 2025.

  • WealthShield Partners reported no remaining CapForce IBD 50 ETF position as of Q4 2025 after selling out during the quarter.
  • WealthShield Partners sold 128 CapForce IBD 50 ETF shares in Q4 2025, an estimated $4.77K.
  • WealthShield Partners first reported a position in CapForce IBD 50 ETF in Q1 2021 and held it in 5 quarters.
  • WealthShield Partners's CapForce IBD 50 ETF position peaked at $76K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2025.

Based on WealthShield Partners's 13F filing for Q4 2025, filed 3 Feb 2026.